GlaxoSmithKline traded at 1,425.00 this Tuesday August 16th, increasing 19.00 or 1.35 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline gained 17.97 percent. Over the last 12 months, its price fell by 6.03 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,410.85 by the end of this quarter and at 1,299.63 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1,425.00
Daily Change
1.35%
Yearly
-6.03%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 142.55 0.26 0.18% 19.13%
Alcon AG 65.52 0.18 0.28% 1.49%
Almirall SA 9.82 0.02 0.15% -31.27%
Amgen 253.15 2.07 0.82% 9.49%
argenx SE 372.80 -2.50 -0.67% 42.18%
Artemis Alpha 325.00 9.50 3.01% -22.25%
AstraZeneca 10,968.00 6.00 0.05% 27.76%
Bayer 54.30 0.74 1.38% 13.46%
Biogen 219.64 -2.74 -1.23% -37.21%
Bristol-Myers Squibb 74.13 -0.40 -0.54% 7.50%
Fresenius Medical Care 37.30 0.60 1.63% -46.39%
Fresenius 24.91 0.27 1.10% -46.90%
Genmab 2,649.00 -43.00 -1.60% -10.57%
Gilead Sciences 66.33 0.12 0.18% -9.17%
Galapagos 54.16 0.12 0.22% 6.89%
GRIFOLS 13.80 0.02 0.11% -32.24%
GlaxoSmithKline 1,425.00 19.00 1.35% -6.03%
Hikma Pharmaceutical 1,550.00 -4.50 -0.29% -39.99%
Eli Lilly 310.31 -3.63 -1.16% 13.79%
Lonza Group 558.40 -11.20 -1.97% -24.38%
Merck 184.00 -1.95 -1.05% -7.16%
Merck & Co 90.59 -0.01 -0.01% 14.92%
Novartis 80.98 0.53 0.66% -6.64%
Orion 46.59 0.05 0.11% 33.50%
Pfizer 49.86 0.11 0.22% -1.11%
Philips 19.89 0.39 2.02% -47.37%
Recordati 42.30 0.03 0.07% -25.19%
Regeneron Pharmaceuticals 648.70 5.41 0.84% 0.19%
Roche Holding 315.65 -2.25 -0.71% -14.69%
Sanofi 86.59 1.47 1.73% -3.02%
Smith & Nephew PLC 1,060.00 -4.50 -0.42% -23.66%
UCB 73.20 -0.22 -0.30% -25.72%

Indexes Price Day Year
GB100 7536 26.91 0.36% 4.94%

GlaxoSmithKline
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.